Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
GPR33 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 33 Similarity and Patent-Risk Signals
8 min read
GPR33 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 33 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR33 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR173 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 173 Similarity and Patent-Risk Signals
8 min read
GPR173 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 173 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR173 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR19 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 19 Similarity and Patent-Risk Signals
8 min read
GPR19 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 19 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR21 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 21 Similarity and Patent-Risk Signals
8 min read
GPR21 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 21 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR174 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 174 Similarity and Patent-Risk Signals
8 min read
GPR174 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 174 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR174 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR150 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 150 Similarity and Patent-Risk Signals
8 min read
GPR150 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 150 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR150 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR162 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 162 Similarity and Patent-Risk Signals
8 min read
GPR162 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 162 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR162 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR152 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 152 Similarity and Patent-Risk Signals
8 min read
GPR152 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 152 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR152 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR160 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 160 Similarity and Patent-Risk Signals
8 min read
GPR160 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 160 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR160 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR132 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 132 Similarity and Patent-Risk Signals
8 min read
GPR132 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 132 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR132 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR148 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 148 Similarity and Patent-Risk Signals
8 min read
GPR148 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 148 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR148 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR141 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 141 Similarity and Patent-Risk Signals
8 min read
GPR141 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 141 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR141 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →